title: [Relationship between Ets-1 expression and angiogenesis, clinicopathological features and survival of patients with gastric carcinoma].
abstract: OBJECTIVE
  To investigate the expression of Ets-1 in gastric carcinoma, para-cancerous tissue and metastatic lymph nodes, and to determine the relationship between Ets-1 expression and clinicopathological features, angiogenesis and survival of patients with gastric carcinoma.
  
  
  METHODS
  Gastric carcinoma tissue microarray was used to determine Ets-1 protein expression by SP immunohistochemical staining in 189 advanced gastric cancer, 54 papacancerous tissues, 41 metastatic lymph nodes and 32 control tissues.
  
  
  RESULTS
  The positive rates for Ets-1 expression of the carcinoma, paracancerous and control tissues were 71.4%, 29.6% and 18.8%, respectively, with a significant difference among the three groups (P < 0.01). In the cancer tissues, the positive rate of Ets-1 protein expression was significantly associated with depth of invasion and lymph node metastasis (P < 0.01), but not associated with degree of differentiation, Lauren's histological type, sex, age, and size of tumor (P > 0.05). The positive rates for Ets-1 expression of the 41 gastric cancer and 41 metastatic lymph nodes were significantly different (P < 0.05). In metastatic lymph nodes, the positive rate for Ets-1 expression was higher. The MVD in Ets-1 positive tumors was higher than that in the Ets-1 negative tumors, with a significant difference (P < 0.05). Kaplan-Meier survival analysis showed that the survival time of Ets-1-negative patients was longer than that of Ets-1-positive patients (P < 0.05). Cox regression analysis showed that Ets-1 expression was not an independent prognostic factor of gastric carcinoma.
  
  
  CONCLUSIONS
  A higher expression of Ets-1 is involved in carcinogenesis, development, invasion, and metastasis of gastric cancer. Ets-1 plays an important role in angiogenesis in gastric cancer. Ets-1 is a useful marker for predicting the outcome for patients with gastric carcinoma, though it is not an independent prognostic indicator.
authors.affiliation: Department of Gastroenterology of the First Hospital of Lanzhou University, Lanzhou, China.
authors.forename: Tao-wen
authors.initials: TW
authors.lastname: Ren
authors.forename: Yong-ning
authors.initials: YN
authors.lastname: Zhou
authors.forename: Jing
authors.initials: J
authors.lastname: Wu
authors.forename: Zhi-yi
authors.initials: ZY
authors.lastname: Zhang
authors.forename: Tian-jun
authors.initials: TJ
authors.lastname: Hao
authors.forename: Juan-xia
authors.initials: JX
authors.lastname: Wang
authors.forename: Shao-jing
authors.initials: SJ
authors.lastname: Zou
authors.forename: Zhao-feng
authors.initials: ZF
authors.lastname: Chen
authors.forename: Shan-Shan
authors.initials: SS
authors.lastname: Huang
authors.forename: Li-Hua
authors.initials: LH
authors.lastname: Zhang
authors.forename: Yue
authors.initials: Y
authors.lastname: Zhao
mesh_terms: D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D055806:Microvessels / Q000378:metabolism / Q000473:pathology*; D008875:Middle Aged; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D009389:Neovascularization, Pathologic / Q000378:metabolism / Q000473:pathology; D016612:Paraffin Embedding; D016016:Proportional Hazards Models; D050784:Proto-Oncogene Protein c-ets-1 / Q000378:metabolism*; D013274:Stomach Neoplasms / Q000378:metabolism* / Q000473:pathology; D015996:Survival Rate
chemical_list: C494041:ETS1 protein, human; D050784:Proto-Oncogene Protein c-ets-1